Cue Biopharma (CUE) Cash from Operations (2017 - 2025)
Cue Biopharma (CUE) posted Cash from Operations of 1076000.0 for Q4 2025, up 88.08% sequentially from 9024000.0 in Q3 2025, and up 88.08% YoY from 572092.34 in Q4 2024.
Cue Biopharma (CUE) Cash from Operations (2017 - 2025) Analysis & Trends
Cue Biopharma has reported Cash from Operations for 9 years, with the latest figure at 1076000.0 in Q4 2025.
- Quarterly Cash from Operations rose 88.08% year-over-year to 1076000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 21687000.0 (up 40.3% YoY) and the FY2025 annual result came in at 21687000.0, up 40.3% from the prior year.
- Cash from Operations improved to 1076000.0 in Q4 2025 per CUE's latest filing, from 9024000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1076000.0 in Q4 2025 and troughed at 12848000.0 in Q2 2022.
- A 5-year average of 8931008.3 and a median of 9777000.0 in 2021 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2021 and 2025: Cash from Operations slumped 52.09% in 2021, then soared 88.08% in 2025.
- Over 5 years, Cash from Operations stood at 10645166.0 in 2021, then gained by 1.23% to 10514000.0 in 2022, then fell by 4.22% to 10958000.0 in 2023, then grew by 17.61% to 9028000.0 in 2024, then surged by 88.08% to 1076000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 1076000.0, 9024000.0, and 3415000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Cue Biopharma | 152.56 Mn | 135.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.08 Mn |
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | -9.02 Mn |
| Sep 30, 2025 | -9.02 Mn |
| Jun 30, 2025 | -3.42 Mn |
| Jun 30, 2025 | -3.42 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Dec 31, 2024 | -9.03 Mn |
| Dec 31, 2024 | -9.03 Mn |
| Sep 30, 2024 | -7.53 Mn |
| Sep 30, 2024 | -7.53 Mn |
| Jun 30, 2024 | -9.99 Mn |
| Jun 30, 2024 | -9.99 Mn |
| Mar 31, 2024 | -9.78 Mn |
| Mar 31, 2024 | -9.78 Mn |
| Dec 31, 2023 | -10.96 Mn |
| Dec 31, 2023 | -10.96 Mn |
| Sep 30, 2023 | -7.80 Mn |
| Sep 30, 2023 | -7.80 Mn |